NEXENTIS TECHNOLOGIES INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 2.34 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-31
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 2.81M shares, a 75.35% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 2.79M shares, a 78.87% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 2.16M shares, a 48.01% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 1.61M shares, a 10.16% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 2.34M shares, a 54.24% increase from fiscal 2020.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 1.52M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | 2.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 2.80M shares derived: average of 2 quarters · filed 2022-03-31 | 2.58M shares derived: average of 3 quarters · filed 2022-03-31 | 2.34M shares 10-K · filed 2022-03-31 | |||
| 2021-09-30 | 2.79M shares 10-Q · filed 2021-11-15 | 2.47M shares derived: average of 2 quarters · filed 2021-11-15 | 2.19M shares 10-Q · filed 2021-11-15 | 2.04M shares derived: average of 4 quarters · filed 2022-03-31 | |||
| 2021-06-30 | 2.16M shares 10-Q · filed 2021-08-16 | 1.88M shares 10-Q · filed 2021-08-16 | 1.79M shares derived: average of 3 quarters · filed 2022-03-31 | 1.73M shares derived: average of 4 quarters · filed 2022-03-31 | |||
| 2021-03-31 | 1.61M shares 10-Q · filed 2021-05-18 | 1.60M shares derived: average of 2 quarters · filed 2022-03-31 | 1.59M shares derived: average of 3 quarters · filed 2022-03-31 | 1.56M shares derived: average of 4 quarters · filed 2022-03-31 | |||
| 2020-12-31 | 1.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 1.58M shares derived: average of 2 quarters · filed 2022-03-31 | 1.54M shares derived: average of 3 quarters · filed 2022-03-31 | 1.52M shares 10-K · filed 2022-03-31 | |||
| 2020-09-30 | 1.56M shares 10-Q · filed 2021-11-15 | 10.90M shares 10-Q · filed 2020-11-12 | 1.51M shares derived: average of 2 quarters · filed 2021-11-15 | 1.49M shares 10-Q · filed 2021-11-15 | 10.44M shares 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | 1.46M shares 10-Q · filed 2021-08-16 | 10.21M shares 10-Q · filed 2020-08-11 | 1.46M shares 10-Q · filed 2021-08-16 | 10.21M shares 10-Q · filed 2020-08-11 | |||
| 2020-03-31 | 1.46M shares 10-Q · filed 2021-05-18 | 10.21M shares 10-Q · filed 2020-05-15 | |||||
| 2019-09-30 | 10.17M shares 10-Q · filed 2020-11-12 | 10.02M shares derived: average of 2 quarters · filed 2020-11-12 | 9.89M shares 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | 9.87M shares 10-Q · filed 2020-08-11 | 9.74M shares 10-Q · filed 2020-08-11 | |||||
| 2019-03-31 | 9.52M shares 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |